Australian researchers, including one of an Indian-origin, have developed a simple, cheap and non-invasive blood test that could help predict a person's risk of developing Alzheimer's disease up to 20 years before symptoms show.Physicists from The Australian National University (ANU) have come up with a way to use nanotechnology, combined with artificial intelligence (AI), to analyse proteins in blood to search for signs of early neurodegeneration, or tell-tale "biomarkers" that point to the onset of Alzheimer's.
The physicists developed an ultra-thin silicon chip containing "nanopores" -- tiny, nanometer-sized holes that analyse the proteins one at a time with help from an advanced AI algorithm. A small amount of blood is placed on the silicon chip and inserted into a portable device, about the size of a mobile phone, which uses the AI algorithm to search for signatures corresponding to the proteins that show signs of early onset Alzheimer's.Although there is no cure for Alzheimer's, ANU researcher Shankar Dutt said knowing whether someone is at risk of developing Alzheimer's 20 years before a potential diagnosis could significantly improve health outcomes for patients.
"If that person can find out their risk level that far in advance, then it gives them plenty of time to start making positive lifestyle changes and adopt medication strategies that may help slow down the progression of the disease," he said.The team said the algorithm, detailed in the journal Small Methods, can be trained to screen for multiple neurological conditions at the same time, including Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis."Currently, Alzheimer's is mostly diagnosed based on evidence of mental deterioration, by which stage the disease has already seriously damaged the brain," said co-author Professor Patrick Kluth, from the ANU Research School of Physics."Early detection, which is vital for effective treatment, normally involves invasive and expensive hospital procedures such as a lumbar puncture, which can be physically and mentally taxing for patients."Our technique, on the other hand, requires only a small blood sample and patients could receive their results in near real-time."The quick and simple test could be done by GPs and other clinicians, which would eliminate the need for a hospital visit and prove especially convenient for people living in regional and remote areas," Kluth saidThe researchers describe finding the proteins with signs of early neurodegeneration like searching for a needle in a haystack."Blood is a complex fluid that contains more than 10,000 different biomolecules. By employing advanced filtration techniques and harnessing our nanopore platform, combined with our intelligent machine learning algorithms, we may be able to identify even the most elusive proteins,".
The researchers describe finding the proteins with signs of early neurodegeneration like searching for a needle in a haystack.
Alzheimer's disease is a progressive and degenerative brain disorder that primarily affects memory, thinking, and behavior. It is the most common cause of dementia, a general term for a decline in cognitive ability severe enough to interfere with daily life. Here are some key points about Alzheimer's disease:
1. **Symptoms:** Alzheimer's disease typically begins with mild memory problems and difficulty in performing familiar tasks. As it progresses, individuals may experience confusion, mood swings, language problems, and eventually severe memory loss.
2. **Brain Changes:** Alzheimer's is associated with abnormal protein deposits in the brain, including beta-amyloid plaques and tau tangles. These deposits interfere with normal brain function and lead to the death of brain cells.
3. **Risk Factors:** While the exact cause of Alzheimer's is not known, several risk factors have been identified, including age (it is more common in older adults), genetics (a family history of the disease increases the risk), and certain lifestyle factors like cardiovascular health.
4. **Diagnosis:** Diagnosis of Alzheimer's disease is typically based on a combination of clinical assessments, cognitive tests, and, in some cases, brain imaging. Early diagnosis is important for better management of the condition.
5. **Treatment:** Currently, there is no cure for Alzheimer's disease. However, there are medications and interventions that can help manage symptoms and improve the quality of life for individuals with Alzheimer's.
6. **Caregiving:** Alzheimer's places a significant burden on caregivers, as individuals with the disease often require increasing levels of assistance with daily activities. Support and resources for caregivers are essential.
7. **Research:** Ongoing research aims to better understand the causes of Alzheimer's and develop more effective treatments. Advances in genetics, neuroimaging, and drug development offer hope for future therapies.
8. **Awareness and Advocacy:** Alzheimer's organizations and advocacy groups work to raise awareness, reduce stigma, and advocate for increased funding and research efforts to combat the disease.
9. **Prevention:** While there are no guaranteed methods to prevent Alzheimer's, adopting a healthy lifestyle that includes regular exercise, a balanced diet, social engagement, and cognitive stimulation may help reduce the risk.
It's important to Alzheimer's disease is a significant global health challenge, and as the population ages, its impact is expected to increase. Early detection, research, and support for both individuals with Alzheimer's and their caregivers are critical components in addressing this disease. If you or someone you know is experiencing symptoms of Alzheimer's, it's essential to seek medical advice for a proper evaluation and diagnosis.
You must be logged in to post a comment.